Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › EP4 receptor selective agonist in the treatment of osteoporosis

EP4 receptor selective agonist in the treatment of osteoporosis

US Patent 7192979 · Granted Mar 20, 2007

Estimated economic value: $254,717,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Bicyclic-heterocycle derivatives and their uses as orexin-2 receptor agonists2025
BCKDK inhibitors and/or degraders2025
Anti-proliferative agents for treating PAH2021
Indole and indazole compounds that activate AMPK2016
Indole and indazole compounds that activate AMPK2014
2,3-dihydro-1H-inden-1-yl-2,7-diazaspiro[3.5] nonane derivatives2013
Dibenzyl amine compounds and derivatives2013
Dibenzyl amine compounds and derivatives2011
Androgen modulators2010
Androgen modulators2010
Androgen modulators2010
Androgen receptor modulators2009